Oleg Blyuss

ORCID: 0000-0002-0194-6389 · 8 papers in corpus
other 2025
Cancers ·doi:10.3390/cancers17243972

Background: Ovarian cancer is characterized by high mortality rates, primarily due to diagnosis at late stages. Current biomarkers, such as CA125, have demonstrated limited efficacy for early detection. While high-dimensional proteomics off…

2023
·doi:10.1136/ijgc-2023-esgo.871
2021
·doi:10.1136/ijgc-2021-esgo.285
other 2020
British journal of cancer ·doi:10.1038/s41416-019-0718-9

BACKGROUND: Ovarian cancer has a poor survival rate due to late diagnosis and improved methods are needed for its early detection. Our primary objective was to identify and incorporate additional biomarkers into longitudinal models to impro…

other 2020
Cancers ·doi:10.3390/cancers12071931

Longitudinal CA125 algorithms are the current basis of ovarian cancer screening. We report on longitudinal algorithms incorporating multiple markers. In the multimodal arm of United Kingdom Collaborative Trial of Ovarian Cancer Screening (U…

other 2020
Cancers ·doi:10.3390/cancers12051241

UNLABELLED: Unselected population-based personalised ovarian cancer (OC) risk assessment combining genetic/epidemiology/hormonal data has not previously been undertaken. We aimed to perform a feasibility study of OC risk stratification of g…

other 2019
Clinical proteomics ·doi:10.1186/s12014-019-9235-3

BACKGROUND: Endometriosis is a common gynaecological disorder affecting 5-10% of women of reproductive age who often experience chronic pelvic pain and infertility. Definitive diagnosis is through laparoscopy, exposing patients to potential…

2019
·doi:10.6084/m9.figshare.7963346

Additional file 2. Results of TMT-based LC-MS/MS profiling with candidate scoring.